着眼糖尿病并发症,降糖与减肥并重——2017年版AACE/ACE2型糖尿病综合管理方案共识声明解读

摘要

Diabetes mellitus is one of the most important chronic non-communicable diseases that threaten human health around the world,and its treatment has always been the focus of research.In 2017,the American Association of Clinical Endocrinologists(AACE)/American Society of Endocrinology(ACE) launched the 2017 version of AACE/ACE consensus statement on the comprehensive type 2 diabetes management algorithm(hereinafter referred to as the 2017 AACE/ACE consensus statement) according to the latest research on diabetes treatment program and the 2016 edition of Food and Drug Administration(FDA) drug update.This paper summarizes the update of the 2017 AACE/ACE consensus statement compared to the 2016 edition,which emphasizes the importance of diabetes complications management,and the necessity of weight loss while reducing blood sugar.In addition,it also provides a brief overview of the differences between AACE/ACE consensus statement and the American Diabetes Association(ADA) guidelines in order to provide a basis for exploring more rational diabetes management programs.%糖尿病是当前威胁全球人类健康最主要的慢性非传染性疾病之一,其治疗方案一直是研究热点.2017年美国临床内分泌医师协会(AACE)/美国内分泌学会(ACE)根据最新的糖尿病治疗研究和2016年美国食品药品监督管理局(FDA)药物更新推出了2017年版AACE/ACE 2型糖尿病综合管理方案共识声明(以下简称2017 AACE/ACE共识声明).本文总结了2017 AACE/ACE共识声明相比于2016年版的更新之处,其强调糖尿病并发症管理的重要性,在降糖的同时需要关注减重的必要性.此外,本文简要介绍了AACE/ACE共识声明和美国糖尿病学会(ADA)指南的区别,旨在为探索更合理的糖尿病管理方案提供依据.